SSR128129E
SSR128129E is an orally bioavailable, allosteric inhibitor that selectively targets FGFR1 with an IC50 of 1.9 μM. Its specificity makes it a valuable research tool for investigating FGFR1 signaling in cancer models, with applications in both in vitro biochemical assays and in vivo xenograft studies.
Product Specifications
CAS Number
848318-25-2
Product Name Alternative
SSR, SSR 128129E, SSR128129E, SSR-128129E, FGFR, FGFR1
Field of Research
Cardiovascular Research, Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
H2O:1 mg/mL (2.89 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.78 mM) ; DMSO:45 mg/mL (129.94 mM)
Smiles
[Na+].COc1c (C) c (C (=O) c2ccc (N) c (c2) C ([O-]) =O) n2ccccc12
Molecular Formula
C18H15N2O4·Na
Molecular Weight
346.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15240148 1 Vial
Lentiviral mouse Map3k7 shRNA (UAS) - Lentiviral mouse Map3k7 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
250107-ML550 100 µL
PIK3R6 (Phosphoinositide-3-Kinase, Regulatory Subunit 6, C17orf38, DKFZp666P158, FLJ34500, HsT41028, p84, p87 (PIKAP), p87PIKAP) (MaxLight 550)
Sign In for Pricing
View Details